Because this product is a synergistic combination of two distinct research peptides, its chemical details are defined by its individual active constituents:
BPC-157 (Body Protection Compound-157)
Chemical Name: L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanyglycyl-L-leucyl-
Molecular Formula: $\text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22}$
Sequence: H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
TB-500 (Thymosin Beta-4 Active Fragment)
Chemical Name: L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-alpha-glutamyl-L-threonyl-
Molecular Formula: $\text{C}_{38}\text{H}_{68}\text{N}_{10}\text{O}_{14}$
Sequence: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH (Ac-LKKTETQ-OH)
Synergistic Tissue and Musculoskeletal Repair: Investigating how the co-administration of BPC-157 and TB-500 influences the acceleration of healing in damaged tendons, ligaments, bone, and skeletal muscle tissue.
Angiogenesis and Vascularization: Evaluating the combined impact of these agents on stimulating endothelial cell proliferation, migration, and the upregulation of vascular endothelial growth factor (VEGF) to promote new blood vessel formation.
Extracellular Matrix (ECM) Remodeling & Actin Polymerization: Examining the interaction between BPC-157’s collagen-promoting pathways and TB-500’s regulation of actin sequestration to facilitate rapid cellular migration and tissue reconstruction.
Systemic and Localized Anti-Inflammatory Cascades: Assessing the downregulation of pro-inflammatory cytokines and the modulation of joint, tissue, and systemic inflammatory responses under acute or chronic damage models.
Cytoprotection and Organ Barrier Integrity: Probing BPC-157’s protective capabilities on gastric and vascular mucosal linings alongside TB-500’s general cellular-survival mechanisms during physiological stress.
Reviews
There are no reviews yet.